New insights into activation and function of the AMPK
GR Steinberg, DG Hardie - Nature reviews Molecular cell biology, 2023 - nature.com
The classical role of AMP-activated protein kinase (AMPK) is as a cellular energy sensor
activated by falling energy status, signalled by increases in AMP to ATP and ADP to ATP …
activated by falling energy status, signalled by increases in AMP to ATP and ADP to ATP …
[HTML][HTML] New insights into oxidative stress and inflammation during diabetes mellitus-accelerated atherosclerosis
T Yuan, T Yang, H Chen, D Fu, Y Hu, J Wang, Q Yuan… - Redox biology, 2019 - Elsevier
Oxidative stress and inflammation interact in the development of diabetic atherosclerosis.
Intracellular hyperglycemia promotes production of mitochondrial reactive oxygen species …
Intracellular hyperglycemia promotes production of mitochondrial reactive oxygen species …
Molecular and cellular mechanisms of cardiovascular disorders in diabetes
MS Shah, M Brownlee - Circulation research, 2016 - Am Heart Assoc
The clinical correlations linking diabetes mellitus with accelerated atherosclerosis,
cardiomyopathy, and increased post-myocardial infarction fatality rates are increasingly …
cardiomyopathy, and increased post-myocardial infarction fatality rates are increasingly …
Non-canonical features of microRNAs: paradigms emerging from cardiovascular disease
D Santovito, C Weber - Nature Reviews Cardiology, 2022 - nature.com
Research showing that microRNAs (miRNAs) are versatile regulators of gene expression
has instigated tremendous interest in cardiovascular research. The overwhelming majority of …
has instigated tremendous interest in cardiovascular research. The overwhelming majority of …
Empagliflozin ameliorates obesity-related cardiac dysfunction by regulating Sestrin2-mediated AMPK-mTOR signaling and redox homeostasis in high-fat diet–induced …
Sodium–glucose cotransporter 2 inhibitors (SGLT2i) have favorable cardiovascular
outcomes in patients with diabetes. However, whether SGLT2i can improve obesity-related …
outcomes in patients with diabetes. However, whether SGLT2i can improve obesity-related …
Resveratrol alleviates diabetic cardiomyopathy in rats by improving mitochondrial function through PGC-1α deacetylation
W Fang, C Wang, Y He, Y Zhou, X Peng… - Acta Pharmacologica …, 2018 - nature.com
Recent evidence shows that resveratrol (RSV) may ameliorate high-glucose-induced
cardiac oxidative stress, mitochondrial dysfunction and myocardial fibrosis in diabetes …
cardiac oxidative stress, mitochondrial dysfunction and myocardial fibrosis in diabetes …
Diet-induced obesity impairs spermatogenesis: A potential role for autophagy
Y Mu, W Yan, T Yin, Y Zhang, J Li, J Yang - Scientific reports, 2017 - nature.com
Autophagy is an evolutionarily conserved process that plays a crucial role in maintaining a
series of cellular functions. It has been found that autophagy is closely involved in the …
series of cellular functions. It has been found that autophagy is closely involved in the …
MicroRNA targets and biomarker validation for diabetes-associated cardiac fibrosis
ZQ Jin - Pharmacological research, 2021 - Elsevier
Cardiac fibrosis is one of the main characteristics of diabetic cardiomyopathy and manifests
excessive accumulation of extracellular matrix proteins in the heart. Several signaling …
excessive accumulation of extracellular matrix proteins in the heart. Several signaling …
miR-133: a suppressor of cardiac remodeling?
N Li, H Zhou, Q Tang - Frontiers in pharmacology, 2018 - frontiersin.org
Cardiac remodeling, which is characterized by mechanical and electrical remodeling, is a
significant pathophysiological process involved in almost all forms of heart diseases …
significant pathophysiological process involved in almost all forms of heart diseases …
Diabetic cardiomyopathy: prevalence, determinants and potential treatments
GS Gulsin, L Athithan… - Therapeutic advances in …, 2019 - journals.sagepub.com
The prevalence of type 2 diabetes (T2D) has reached a pandemic scale. These patients are
at a substantially elevated risk of developing cardiovascular disease, with heart failure (HF) …
at a substantially elevated risk of developing cardiovascular disease, with heart failure (HF) …